News|Videos|February 14, 2025
Approach to Long-Term Management of CAR-T MM Patients
The discussion delves into long-term monitoring strategies for CAR-T patients, exploring differences between academic and community settings and emerging long-term adverse effects as clinical experience with CAR-T therapy grows.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- What is your approach to the long-term monitoring of CAR-T patients?
- In what ways does this monitoring vary between academic and community settings?
- Are there any new long-term adverse effects emerging as we gain more experience with CAR-T therapy?
Advertisement
Related to this article
Coral Omene, MD, PhD, discusses the clinical impact of breast cancer disparities and how oncology nurses can support diverse trial recruitment.
An ONS review presented at EONS19 outlines 7 system-level employer strategies to curb oncology nurse burnout and improve retention.
A Columbia nurse scientist shares her takeaways from the 2026 ASCO Quality Care Symposium, from geriatric assessment to care across the age span.
A patient, a caregiver, nurses, an NP, and an oncologist discuss rash prevention, dose holds, cost, and trial eligibility with oral daraxonrasib.
In a 117-patient cohort, 35% waited over 60 days for neoadjuvant chemotherapy, most often because of added workup, second opinions or comorbidities.
Interviews with 15 young women with breast cancer show fertility preservation decisions unfold under time pressure and carry into survivorship.
Lisa Carter-Bawa, PhD, MPH, APRN, explains how nurses can counter lung cancer fatalism by pairing honesty with hope and using teach-back.
Interim AYA-NAV data show most navigation components reached young patients with cancer as designed, though full sessions lagged during treatment.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
FDA Approves Pimicotinib for Symptomatic Tenosynovial Giant Cell Tumor
2
Oncology Nurse Burnout: An Employer Blueprint From EONS19
3
Patients, Nurses Share What Daraxonrasib Means in Practice
4
How a Nurse's Question Changed Stem Cell Infusion Practice at UC Davis
5